Is oral intermittent calcitriol more effective than daily calcitriol therapy in suppressing overt secondary hyperparathyroidism in predialysis patients? Reply

被引：0
作者：
Watanabe, Y
机构：
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 1997年 / 12卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：366 / 367
页数：2
相关论文
共 6 条
[1]  
HERMANN P, 1994, NEPHRON, V67, P48
[2]   LOW-DOSE CALCITRIOL VERSUS PLACEBO IN PATIENTS WITH PREDIALYSIS CHRONIC RENAL-FAILURE [J].
NORDAL, KP ;
DAHL, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 67 (05) :929-936
[3]   OPTIMUM-MODE OF ADMINISTRATION OF VITAMIN-D IN RENAL-FAILURE - INSIGHTS FROM EXPERIMENTAL-DATA [J].
REICHEL, H .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 :33-36
[4]  
SEIDEL A, 1993, CLIN NEPHROL, V39, P210
[5]   ROLE OF 1,25-DIHYDROXYVITAMIN D3 IN MAINTAINING SERUM PHOSPHORUS AND CURING RICKETS [J].
TANAKA, Y ;
DELUCA, HF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1974, 71 (04) :1040-1044
[6]  
WATANABE Y, 1990, NEPHROL DIAL TRANSPL, V11, P910
1